ENTA — Enanta Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Enanta Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	244	249	370	248	189
Net Total Accounts Receivable
Net Total Receivables	60.8	49	39.6	38.6	6.88
Prepaid Expenses
Total Other Current Assets
Total Current Assets	319	312	423	300	204
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.7	29.7	34.7	73.3	72.9
Long Term Investments
Other Long Term Assets
Total Assets	439	375	462	377	281
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	36.2	29.8	62.8	57.5	48.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	39.4	54.1	246	248	216
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	399	321	217	129	64.7
Total Liabilities & Shareholders' Equity	439	375	462	377	281
Total Common Shares Outstanding